218 related articles for article (PubMed ID: 1831034)
1. Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS.
Oncology (Williston Park); 1991 Apr; 5(4):16, 18-9. PubMed ID: 1831034
[No Abstract] [Full Text] [Related]
2. Can single-patient investigational new drug studies hurry slow trains to the fast track?
Chenoweth D
Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
[TBL] [Abstract][Full Text] [Related]
3. Cancer and AIDS groups push for changes in drug approval process.
Anderson LF
J Natl Cancer Inst; 1989 Jun; 81(11):829-31. PubMed ID: 2724348
[No Abstract] [Full Text] [Related]
4. Expanded availability of dideoxyinosine (ddI) for AIDS.
J Am Osteopath Assoc; 1989 Dec; 89(12):1507-8, 1511. PubMed ID: 2516079
[No Abstract] [Full Text] [Related]
5. Hiding behind agency discretion: the Food and Drug Administration's personal use drug importation policy.
Reichertz PS; Friend MS
Cornell J Law Public Policy; 2000; 9():493-521. PubMed ID: 11067734
[No Abstract] [Full Text] [Related]
6. FDA approves AIDS drug.
Am Pharm; 1992 Sep; NS32(9):13-4. PubMed ID: 1332462
[No Abstract] [Full Text] [Related]
7. New drug initiatives announced.
Ann Pharmacother; 1992 Jun; 26(6):868. PubMed ID: 1611177
[No Abstract] [Full Text] [Related]
8. The fast track toward new AIDS drugs.
Long K; Long R
Nurse Pract Forum; 1991 Jun; 2(2):80-1. PubMed ID: 1840952
[No Abstract] [Full Text] [Related]
9. Payment for drug therapy.
McGivney WT
Physician Exec; 1990; 16(1):39-40. PubMed ID: 10113124
[TBL] [Abstract][Full Text] [Related]
10. The fast track: federal agencies and the political demand for AIDS drugs.
Foreman CH
Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828
[No Abstract] [Full Text] [Related]
11. Drug approval and AIDS: benefits for the elderly.
Rothman DJ; Edgar H
Health Aff (Millwood); 1990; 9(3):123-30. PubMed ID: 2227773
[No Abstract] [Full Text] [Related]
12. The scientific agenda for AIDS.
Fauci AS
Issues Sci Technol; 1988; 4(2):33-42. PubMed ID: 10287932
[No Abstract] [Full Text] [Related]
13. Expanded availability of investigational new drugs through a parallel track mechanism for people with AIDS and other HIV-related disease--PHS. Notice final policy statement.
Fed Regist; 1992 Apr; 57(73):13250-9. PubMed ID: 10118459
[TBL] [Abstract][Full Text] [Related]
14. DdI approval offers second chance.
Albert SG
Am Pharm; 1991 Dec; NS31(12):6. PubMed ID: 1763779
[No Abstract] [Full Text] [Related]
15. Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule.
Fed Regist; 1992 Apr; 57(73):13244-9. PubMed ID: 10118458
[TBL] [Abstract][Full Text] [Related]
16. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy?
Lovell MC
Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202
[No Abstract] [Full Text] [Related]
17. National panel studies approval process for AIDS & cancer drugs.
Dimens Crit Care Nurs; 1990; 9(2):66. PubMed ID: 2328642
[No Abstract] [Full Text] [Related]
18. AIDS drugs in development. Facts and comparisons.
Hosp Pharm; 1993 Feb; 28(2):161, 165-7. PubMed ID: 10125704
[No Abstract] [Full Text] [Related]
19. Your money or their lives. Patient advocates are learning from AIDS activists how to work the system.
Thompson D
Time; 1992 Oct; 140(15):66-8. PubMed ID: 10121154
[No Abstract] [Full Text] [Related]
20. New AIDS programs may improve system.
Am Fam Physician; 1989 Jan; 39(1):23-4. PubMed ID: 2911957
[No Abstract] [Full Text] [Related]
[Next] [New Search]
